ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Biotechnology

Healthcare
$12.82 +0.73%

+$0.13 today

Market cap
$1.42B
Beta
0.00
52W Low $16.64High $23.21

Volume 0.65M

Average 1.06M

ADRX Property, Plant & Equipment (Net)

Physical long-term assets such as land, buildings, and machinery, net of accumulated depreciation.

No reported Property, Plant & Equipment (Net) figures are available to summarize.

Property, Plant & Equipment (Net) history

Currency unavailable · from the balance sheet

No Property, Plant & Equipment (Net) data reported for this period type.

Property, Plant & Equipment (Net) vs competitors

How ADRX compares with its peers on the latest reported figures

ADRX Competitors
Property, Plant & Equipment (Net) for ADRX and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
PRMEPrime Medicine, Inc.Mar 2026$142.15M USD-5.4%+44.6%48.2%
MGTXMeiraGTx Holdings plcMar 2026$137.53M USD+3.0%-2.7%56.2%
ARCTArcturus Therapeutics Holdings Inc.Mar 2026$26.5M USD-23.4%-14.8%10.8%
WVEWave Life Sciences Ltd.Mar 2026$18.07M USD-30.9%-23.4%3.1%
PRQRProQR Therapeutics N.V.Mar 2026€12.06M EUR-17.9%-8.1%12.2%
RNAAtrium Therapeutics, Inc.Mar 2026$6.38M USD——2.2%
STOKStoke Therapeutics, Inc.Mar 2026$5.89M USD-20.9%-18.2%1.3%
SLNSilence Therapeutics plcMar 2026$1.54M USD-14.6%-7.4%1.3%
BNTCBenitec Biopharma Inc.Mar 2026$916K USD-17.4%-0.1%0.5%
ADRXADARx Pharmaceuticals, Inc.—— ———
Peer median (excluding ADRX) —-17.7%-7.7%3.1%

Competitors are the stored peer set for ADRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

ADARx Pharmaceuticals, Inc.

NASDAQ:ADRX

Intrinsic Alpha fair value

Locked

Current Price

$12.82

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.